MetLife Non Current Liabilities Other from 2010 to 2024

MET Stock  USD 88.25  0.49  0.56%   
MetLife Non Current Liabilities Other yearly trend continues to be comparatively stable with very little volatility. Non Current Liabilities Other will likely drop to about 568.7 B in 2024. From the period from 2010 to 2024, MetLife Non Current Liabilities Other quarterly data regression had r-value of (0.58) and coefficient of variation of  12.58. View All Fundamentals
 
Non Current Liabilities Other  
First Reported
2010-12-31
Previous Quarter
636.1 B
Current Value
642 B
Quarterly Volatility
80.9 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MetLife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MetLife's main balance sheet or income statement drivers, such as Depreciation And Amortization of 478 M, Interest Expense of 795.6 M or Selling General Administrative of 5.8 B, as well as many indicators such as Price To Sales Ratio of 0.72, Dividend Yield of 0.0225 or PTB Ratio of 1.76. MetLife financial statements analysis is a perfect complement when working with MetLife Valuation or Volatility modules.
  
Check out the analysis of MetLife Correlation against competitors.
For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Latest MetLife's Non Current Liabilities Other Growth Pattern

Below is the plot of the Non Current Liabilities Other of MetLife over the last few years. It is MetLife's Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MetLife's overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Other10 Years Trend
Slightly volatile
   Non Current Liabilities Other   
       Timeline  

MetLife Non Current Liabilities Other Regression Statistics

Arithmetic Mean694,585,991,111
Geometric Mean689,444,522,393
Coefficient Of Variation12.58
Mean Deviation75,240,008,296
Median678,003,000,000
Standard Deviation87,376,566,259
Sample Variance7634664331.2T
Range245.8B
R-Value(0.58)
Mean Square Error5442533567.4T
R-Squared0.34
Significance0.02
Slope(11,359,760,476)
Total Sum of Squares106885300637.3T

MetLife Non Current Liabilities Other History

2024568.7 B
2023571.5 B
2022635 B
2021678 B
2020704.8 B
2019660.2 B
2018624.2 B

About MetLife Financial Statements

MetLife shareholders use historical fundamental indicators, such as Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Although MetLife investors may analyze each financial statement separately, they are all interrelated. The changes in MetLife's assets and liabilities, for example, are also reflected in the revenues and expenses on on MetLife's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Liabilities Other571.5 B568.7 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.